|
|
|
Corporate Profile: Savient Pharmaceuticals
| Summary: |
Savient Pharmaceuticals is focused on the commercialization of a treatment for chronic gout in patients refractory to conventional therapy and branded and generic versions of oxandrolone, which is perscribed to promote weight gain following involuntary weight loss.
|
| Address: |
One Tower Center
Fourteenth Floor
East Brunswick, NJ 08816 |
| Phone
#'s: |
| Main |
(732) 418-9300 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax
#'s: |
| Main |
(732) 418-0570 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| email: |
| Main |
not known
|
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Financial
information: |
| SVNT |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
